SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-161506
Filing Date
2011-06-09
Accepted
2011-06-09 06:02:39
Documents
6
Period of Report
2011-06-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15844
2 PRESS RELEASE dex991.htm EX-99.1 12191
3 GRAPHIC g196119g05x32.jpg GRAPHIC 162501
4 GRAPHIC g196119g28z80.jpg GRAPHIC 236914
5 GRAPHIC g196119g30p61.jpg GRAPHIC 210060
6 GRAPHIC g196119g85q54.jpg GRAPHIC 244997
  Complete submission text file 0001193125-11-161506.txt   1207009
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 11902069
SIC: 2834 Pharmaceutical Preparations